Full Text View
Tabular View
No Study Results Posted
Related Studies
Survival Of Subjects With Chronic Obstructive Pulmonary Disease (COPD)
This study has been completed.
First Received: December 20, 2005   Last Updated: November 5, 2009   History of Changes
Sponsor: GlaxoSmithKline
Information provided by: GlaxoSmithKline
ClinicalTrials.gov Identifier: NCT00268216
  Purpose

The purpose of this study is to see if fluticasone 500mcg/salmeterol 50mcg can improve the survival of subjects with COPD and also assess the long term safety profile of this drug.


Condition Intervention Phase
Chronic Obstructive Pulmonary Disease (COPD)
Drug: Salmeterol 50mcg/ Fluticasone Propionate 500mcg
Phase III

Study Type: Interventional
Study Design: Treatment, Randomized, Double-Blind, Parallel Assignment, Safety/Efficacy Study
Official Title: See Detailed Description

Resource links provided by NLM:


Further study details as provided by GlaxoSmithKline:

Primary Outcome Measures:
  • All cause mortality at 3 years

Secondary Outcome Measures:
  • Rate of moderate and severe COPD exacerbations and health status assessed by the St. George's Respiratory Questionnaire.

Estimated Enrollment: 6040
Study Start Date: September 2000
Detailed Description:

A multicenter, randomized, double-blind, parallel group, placebo controlled study to investigate the effects of salmeterol/fluticasone 50/500mcg bd, salmeterol 50mcg bd, and fluticasone 500mcg bd, all delivered via the DISKUS/ACCUHALER inhaler, on the survival of subjects with chronic obstructive pulmonary disease over 3 years of treatment.

  Eligibility

Ages Eligible for Study:   40 Years to 80 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion criteria:

  • Patients with COPD and FEV1 <60% of predicted normal and baseline (pre-bronchodilator) FEV1/FVC ratio <70%.
  • Current or ex-smokers with a smoking history of at least 10 pack-years.

Exclusion criteria:

  • Diagnosis of other respiratory disorders (including asthma).
  • Requirement for long term oxygen therapy.
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00268216

  Hide Study Locations
Locations
United States, Alabama
GSK Investigational Site
Ozark, Alabama, United States, 36360
GSK Investigational Site
Birmingham, Alabama, United States, 35294
GSK Investigational Site
Birmingham, Alabama, United States, 35294-7340
GSK Investigational Site
Birmingham, Alabama, United States, 35235
GSK Investigational Site
Jasper, Alabama, United States, 35501
GSK Investigational Site
Mobile, Alabama, United States, 36608
United States, Arizona
GSK Investigational Site
Phoenix, Arizona, United States, 85008
GSK Investigational Site
Scottsdale, Arizona, United States, 85251
GSK Investigational Site
Phoenix, Arizona, United States, 85006
United States, California
GSK Investigational Site
San Diego, California, United States, 92103
GSK Investigational Site
Burbank, California, United States, 91505
GSK Investigational Site
San Francisco, California, United States, 94102
GSK Investigational Site
San Luis Obispo, California, United States, 93401
GSK Investigational Site
Berkeley, California, United States, 94705
GSK Investigational Site
Riverside, California, United States, 92506
GSK Investigational Site
Fullerton, California, United States, 92835
GSK Investigational Site
Vista, California, United States, 92083
GSK Investigational Site
Fresno, California, United States, 93710
GSK Investigational Site
Encinitas, California, United States, 92024
GSK Investigational Site
San Diego, California, United States, 92117
GSK Investigational Site
Walnut Creek, California, United States, 94598
GSK Investigational Site
Stockton, California, United States, 95207
GSK Investigational Site
Sylmar, California, United States, 91342-1495
GSK Investigational Site
Sunnyvale, California, United States, 94086
GSK Investigational Site
Rancho Mirage, California, United States, 92270
GSK Investigational Site
San Diego, California, United States, 92103-6204
GSK Investigational Site
San Diego, California, United States, 92123
GSK Investigational Site
San Diego, California, United States, 92120
GSK Investigational Site
Sepuldeva, California, United States, 91343
GSK Investigational Site
Long Beach, California, United States, 90822
GSK Investigational Site
Los Angeles, California, United States, 90048
GSK Investigational Site
San Francisco, California, United States, 94102
United States, Colorado
GSK Investigational Site
Longmont, Colorado, United States, 80501
GSK Investigational Site
Arvada, Colorado, United States, 80002
GSK Investigational Site
Loveland, Colorado, United States, 80538
GSK Investigational Site
Denver, Colorado, United States, 80218
GSK Investigational Site
Fort Collins, Colorado, United States, 80528
GSK Investigational Site
Denver, Colorado, United States, 80206
GSK Investigational Site
Wheat Ridge, Colorado, United States, 80033
United States, Connecticut
GSK Investigational Site
Hartford, Connecticut, United States, 06105
GSK Investigational Site
Stamford, Connecticut, United States, 06902
United States, Florida
GSK Investigational Site
Pensacola, Florida, United States, 32514
GSK Investigational Site
Pace, Florida, United States, 32571
GSK Investigational Site
Jacksonville, Florida, United States, 32205
GSK Investigational Site
Tamarac, Florida, United States, 33321
GSK Investigational Site
Loxahatchee, Florida, United States, 33470
GSK Investigational Site
Sarasota, Florida, United States, 34239
GSK Investigational Site
Atlantis, Florida, United States, 33462
GSK Investigational Site
Palm Springs, Florida, United States, 33461
GSK Investigational Site
Jacksonville, Florida, United States, 32216
GSK Investigational Site
Altamonte Springs, Florida, United States, 32701
GSK Investigational Site
Longwood, Florida, United States, 32779
GSK Investigational Site
Bay Pines, Florida, United States, 33744
GSK Investigational Site
Largo, Florida, United States, 33770
GSK Investigational Site
West Palm Beach, Florida, United States, 33409
GSK Investigational Site
Miami, Florida, United States, 33136
GSK Investigational Site
Brandon, Florida, United States, 33511
GSK Investigational Site
Zephyrhills, Florida, United States, 33540
GSK Investigational Site
Clearwater, Florida, United States, 33756
GSK Investigational Site
Tampa, Florida, United States, 33613
GSK Investigational Site
Fort Lauderdale, Florida, United States, 33316
United States, Georgia
GSK Investigational Site
Augusta, Georgia, United States, 30901
GSK Investigational Site
Marietta, Georgia, United States, 30066
GSK Investigational Site
Decatur, Georgia, United States, 30033
GSK Investigational Site
Blue Ridge, Georgia, United States, 30513
GSK Investigational Site
Rome, Georgia, United States, 30165
GSK Investigational Site
Atlanta, Georgia, United States, 30342
GSK Investigational Site
Roswell, Georgia, United States, 30076
United States, Idaho
GSK Investigational Site
Coeur D'Alene, Idaho, United States, 83814
United States, Illinois
GSK Investigational Site
Champaign, Illinois, United States, 61821
GSK Investigational Site
Chicago, Illinois, United States, 60612-3824
GSK Investigational Site
Peoria, Illinois, United States, 61602
GSK Investigational Site
Chicago, Illinois, United States, 60612-7323
GSK Investigational Site
Hines, Illinois, United States, 60141-5099
GSK Investigational Site
North Chicago, Illinois, United States, 60064
United States, Indiana
GSK Investigational Site
South Bend, Indiana, United States, 46617
United States, Iowa
GSK Investigational Site
Dubuque, Iowa, United States, 52001
United States, Kansas
GSK Investigational Site
Wichita, Kansas, United States, 67208
GSK Investigational Site
Wichita, Kansas, United States, 67207
United States, Kentucky
GSK Investigational Site
Lexington, Kentucky, United States, 40536
GSK Investigational Site
Louisville, Kentucky, United States, 40215
United States, Louisiana
GSK Investigational Site
Shreveport, Louisiana, United States, 71103
GSK Investigational Site
Sunset, Louisiana, United States, 70584
GSK Investigational Site
Lafayette, Louisiana, United States, 70503
United States, Maryland
GSK Investigational Site
Baltimore, Maryland, United States, 21204
GSK Investigational Site
Baltimore, Maryland, United States, 21224
United States, Massachusetts
GSK Investigational Site
Swansea, Massachusetts, United States, 02777
GSK Investigational Site
Boston, Massachusetts, United States, 02135
United States, Michigan
GSK Investigational Site
St. Joseph, Michigan, United States, 49085
GSK Investigational Site
Cadillac, Michigan, United States, 49601
GSK Investigational Site
Traverse City, Michigan, United States, 49684
GSK Investigational Site
Livonia, Michigan, United States, 48152
United States, Minnesota
GSK Investigational Site
Edina, Minnesota, United States, 55438
GSK Investigational Site
Minneapolis, Minnesota, United States, 55417
United States, Mississippi
GSK Investigational Site
Jackson, Mississippi, United States, 39202
United States, Missouri
GSK Investigational Site
St. Charles, Missouri, United States, 63301
GSK Investigational Site
Kansas City, Missouri, United States, 64108
GSK Investigational Site
St. Louis, Missouri, United States, 63110
GSK Investigational Site
Chesterfield, Missouri, United States, 63017
GSK Investigational Site
Jefferson City, Missouri, United States, 65109
United States, Montana
GSK Investigational Site
Billings, Montana, United States, 59102
United States, Nebraska
GSK Investigational Site
Omaha, Nebraska, United States, 68124
GSK Investigational Site
Omaha, Nebraska, United States, 68134
GSK Investigational Site
Omaha, Nebraska, United States, 68105
GSK Investigational Site
Omaha, Nebraska, United States, 68198-2456
GSK Investigational Site
Omaha, Nebraska, United States, 68198
United States, Nevada
GSK Investigational Site
Las Vegas, Nevada, United States, 89104
United States, New Hampshire
GSK Investigational Site
Lebanon, New Hampshire, United States, 03756
GSK Investigational Site
Gilford, New Hampshire, United States, 3249
United States, New Jersey
GSK Investigational Site
Trenton, New Jersey, United States, 8629
GSK Investigational Site
East Orange, New Jersey, United States, 07018
GSK Investigational Site
New Brunswick, New Jersey, United States, 8901
GSK Investigational Site
Summit, New Jersey, United States, 07091
GSK Investigational Site
Newark, New Jersey, United States, 07112
United States, New Mexico
GSK Investigational Site
Albuquerque, New Mexico, United States, 87108
United States, New York
GSK Investigational Site
Albany, New York, United States, 12208
GSK Investigational Site
Brooklyn, New York, United States, 11217
GSK Investigational Site
New York, New York, United States, 10016
GSK Investigational Site
Mineola, New York, United States, 11501
GSK Investigational Site
Bronxville, New York, United States, 10708
GSK Investigational Site
Great Neck, New York, United States, 11023
GSK Investigational Site
Albany, New York, United States, 12205
GSK Investigational Site
New York, New York, United States, 10029
GSK Investigational Site
New York, New York, United States, 10011
GSK Investigational Site
Buffalo, New York, United States, 14221
United States, North Carolina
GSK Investigational Site
Chapel Hill, North Carolina, United States, 27514
GSK Investigational Site
Winston-Salem, North Carolina, United States, 27157
GSK Investigational Site
High Point, North Carolina, United States, 27262
GSK Investigational Site
Wilmington, North Carolina, United States, 28401
GSK Investigational Site
Greenville, North Carolina, United States, 27834
GSK Investigational Site
Elizabeth City, North Carolina, United States, 27909
GSK Investigational Site
Winston-Salem, North Carolina, United States, 27103
GSK Investigational Site
Charlotte, North Carolina, United States, 28207
United States, Ohio
GSK Investigational Site
Franklin, Ohio, United States, 45005
GSK Investigational Site
Toledo, Ohio, United States, 43617
GSK Investigational Site
Cincinnati, Ohio, United States, 45267-0405
GSK Investigational Site
Cleveland, Ohio, United States, 44024
GSK Investigational Site
Toledo, Ohio, United States, 43614-5809
GSK Investigational Site
Cincinnati, Ohio, United States, 45219
United States, Oklahoma
GSK Investigational Site
Oklahoma City, Oklahoma, United States, 73104
United States, Oregon
GSK Investigational Site
Portland, Oregon, United States, 97213
GSK Investigational Site
Lake Oswego, Oregon, United States, 97035
GSK Investigational Site
Portland, Oregon, United States, 97213-2281
GSK Investigational Site
Medford, Oregon, United States, 97504
United States, Pennsylvania
GSK Investigational Site
Pittsburgh, Pennsylvania, United States, 15218
GSK Investigational Site
Ridley Park, Pennsylvania, United States, 19078
GSK Investigational Site
Pittsburgh, Pennsylvania, United States, 15213
GSK Investigational Site
Philadelphia, Pennsylvania, United States, 19129
GSK Investigational Site
Erie, Pennsylvania, United States, 16508
GSK Investigational Site
Philadelphia, Pennsylvania, United States, 19140
GSK Investigational Site
Allentown, Pennsylvania, United States, 18104
GSK Investigational Site
Downington, Pennsylvania, United States, 19335
GSK Investigational Site
Doylestown, Pennsylvania, United States, 8901
United States, Rhode Island
GSK Investigational Site
East Providence, Rhode Island, United States, 02914
GSK Investigational Site
Cranston, Rhode Island, United States, 02920
United States, South Carolina
GSK Investigational Site
Greer, South Carolina, United States, 29651
GSK Investigational Site
Charleston, South Carolina, United States, 29406-7108
GSK Investigational Site
Charleston, South Carolina, United States, 29403
GSK Investigational Site
Spartanburg, South Carolina, United States, 29303
GSK Investigational Site
Simpsonville, South Carolina, United States, 29681
United States, Tennessee
GSK Investigational Site
Milan, Tennessee, United States, 38372
GSK Investigational Site
Johnson City, Tennessee, United States, 37601
GSK Investigational Site
Morristown, Tennessee, United States, 37813
GSK Investigational Site
Bristol, Tennessee, United States, 37620
GSK Investigational Site
Kingsport, Tennessee, United States, 37660
United States, Texas
GSK Investigational Site
Houston, Texas, United States, 77074
GSK Investigational Site
Corsicana, Texas, United States, 75110
GSK Investigational Site
Houston, Texas, United States, 77030
GSK Investigational Site
Houston, Texas, United States, 77024
GSK Investigational Site
San Antonio, Texas, United States, 78205
GSK Investigational Site
San Antonio, Texas, United States, 78217
United States, Utah
GSK Investigational Site
Salt Lake City, Utah, United States, 84102
United States, Virginia
GSK Investigational Site
Chesapeake, Virginia, United States, 23320
GSK Investigational Site
Fredericksburg, Virginia, United States, 22401
GSK Investigational Site
Virginia Beach, Virginia, United States, 23454
GSK Investigational Site
Richmond, Virginia, United States, 23249
GSK Investigational Site
Richmond, Virginia, United States, 23225
GSK Investigational Site
Roanoke, Virginia, United States, 24016
United States, Washington
GSK Investigational Site
Spokane, Washington, United States, 99204
GSK Investigational Site
Spokane, Washington, United States, 99202
GSK Investigational Site
Bellingham, Washington, United States, 98226
United States, West Virginia
GSK Investigational Site
Charleston, West Virginia, United States, 25304
GSK Investigational Site
Huntington, West Virginia, United States, 25701-1693
United States, Wisconsin
GSK Investigational Site
La Crosse, Wisconsin, United States, 54601
GSK Investigational Site
Madison, Wisconsin, United States, 53705
Argentina
GSK Investigational Site
Buenos Aires, Argentina, 1272
Argentina, Buenos Aires
GSK Investigational Site
Vicente López, Buenos Aires, Argentina, 1602
GSK Investigational Site
La Plata, Buenos Aires, Argentina, 1900
Australia, New South Wales
GSK Investigational Site
North Gosford, New South Wales, Australia, 2250
GSK Investigational Site
Bankstown, New South Wales, Australia, 22000
GSK Investigational Site
Camperdown, New South Wales, Australia, 2050
Australia, South Australia
GSK Investigational Site
Toorak Gardens, South Australia, Australia, 5065
GSK Investigational Site
Adelaide, South Australia, Australia, 5000
Australia, Victoria
GSK Investigational Site
Melbourne, Victoria, Australia, 3004
GSK Investigational Site
Melbourne, Victoria, Australia, 3050
GSK Investigational Site
Frankston, Victoria, Australia, 3199
GSK Investigational Site
Geelong, Victoria, Australia, 3220
GSK Investigational Site
Heidelberg, Victoria, Australia, 3084
Australia, Western Australia
GSK Investigational Site
Nedlands, Western Australia, Australia, 6009
Austria
GSK Investigational Site
Vienna, Austria, A-1210
GSK Investigational Site
Wels, Austria, A-4600
GSK Investigational Site
Vienna, Austria, A-1120
GSK Investigational Site
Vienna, Austria, A-1030
Belgium
GSK Investigational Site
Veurne, Belgium, 8630
GSK Investigational Site
Orp-Jauche, Belgium, 1350
GSK Investigational Site
Oostende, Belgium, 8400
GSK Investigational Site
Namur, Belgium, 5000
GSK Investigational Site
Bruxelles, Belgium, 1180
Brazil
GSK Investigational Site
Rio de Janeiro, Brazil, 20221-903
GSK Investigational Site
Rio de Janeiro, Brazil, 20 551-030
GSK Investigational Site
Rio de Janeiro, Brazil, 21941-590
GSK Investigational Site
São Paulo, Brazil, 05403-900
Brazil, Rio Grande Do Sul
GSK Investigational Site
Porto Alegre, Rio Grande Do Sul, Brazil, 40110-160
GSK Investigational Site
Porto Alegre, Rio Grande Do Sul, Brazil, 90035 003
Brazil, São Paulo
GSK Investigational Site
Santo Andre, São Paulo, Brazil, 09060-670
Bulgaria
GSK Investigational Site
Varna, Bulgaria, 9010
GSK Investigational Site
Sofia, Bulgaria, 1202
GSK Investigational Site
Pleven, Bulgaria, 5800
Canada
GSK Investigational Site
Quebec, Canada, G1S 4L8
Canada, Alberta
GSK Investigational Site
Calgary, Alberta, Canada, T2N 4N1
GSK Investigational Site
Calgary, Alberta, Canada, T2V 1P9
GSK Investigational Site
Edmonton, Alberta, Canada, T6L 5X8
Canada, British Columbia
GSK Investigational Site
Maple Ridge, British Columbia, Canada, V2X 2L5
Canada, New Brunswick
GSK Investigational Site
Saint John, New Brunswick, Canada, E2M 3W5
Canada, Newfoundland and Labrador
GSK Investigational Site
Saint John's, Newfoundland and Labrador, Canada, A1B 3V6
Canada, Ontario
GSK Investigational Site
Scarborough, Ontario, Canada, M1B 4Z8
GSK Investigational Site
Windsor, Ontario, Canada, N8X 3V6
GSK Investigational Site
Mississauga, Ontario, Canada, L5M 2V8
GSK Investigational Site
Thunder Bay, Ontario, Canada, P7A 4V7
GSK Investigational Site
Toronto, Ontario, Canada, M6H 3M2
GSK Investigational Site
Mississauga, Ontario, Canada, L5A 1N1
Canada, Quebec
GSK Investigational Site
Sainte-Foy, Quebec, Canada, G1V 4G5
GSK Investigational Site
Sherbrooke, Quebec, Canada, J1H 4J6
GSK Investigational Site
Montreal, Quebec, Canada, H2X 2P4
GSK Investigational Site
Sherbrooke, Quebec, Canada, J1H 1Z1
Chile, Región De La Araucania
GSK Investigational Site
Temuco, Región De La Araucania, Chile
Chile, Región Metro De Santiago
GSK Investigational Site
Santiago, Región Metro De Santiago, Chile, 7500691
Chile, Valparaíso
GSK Investigational Site
Valparaiso, Valparaíso, Chile, 2352499
China
GSK Investigational Site
Shanghai, China, 200025
GSK Investigational Site
Beijing, China, 100034
GSK Investigational Site
Chongqing, China, 400037
GSK Investigational Site
Beijing, China, 100036
GSK Investigational Site
Beijing, China, 100039
GSK Investigational Site
Beijing, China, 100037
GSK Investigational Site
Wangfujing, Beijing, China, 100730
China, Guangdong
GSK Investigational Site
Guangzhou, Guangdong, China, 510120
China, Jiangsu
GSK Investigational Site
Nanjing, Jiangsu, China, 210002
China, Liaoning
GSK Investigational Site
Shenyang, Liaoning, China, 110015
China, Shaanxi
GSK Investigational Site
Xian, Shaanxi, China, 710061
Croatia
GSK Investigational Site
Zagreb, Croatia, 10000
Czech Republic
GSK Investigational Site
Jaromer, Czech Republic, 551 01
GSK Investigational Site
Tabor, Czech Republic, 390 19
GSK Investigational Site
Praha 8, Czech Republic, 182 00
GSK Investigational Site
Ostrava - Fifejdy, Czech Republic, 728 80
GSK Investigational Site
Praha 8, Czech Republic, 180 81
GSK Investigational Site
Hradec Kralove, Czech Republic, 500 05
GSK Investigational Site
Praha 5, Czech Republic, 150 06
Denmark
GSK Investigational Site
Hvidovre, Denmark, 2650
GSK Investigational Site
Aarhus C, Denmark, DK-8000
GSK Investigational Site
Silkenborg, Denmark, DK-8600
GSK Investigational Site
Kobenhavn Nv, Denmark, 2400
Estonia
GSK Investigational Site
Tallinn, Estonia, 13419
GSK Investigational Site
Kohtal-Jdrve, Estonia, 31 025
GSK Investigational Site
Tartu, Estonia, 51014
Finland
GSK Investigational Site
Vantaa, Finland, 01400
GSK Investigational Site
Helsinki, Finland, 00029
GSK Investigational Site
Lappeenranta, Finland, 53130
GSK Investigational Site
Helsinki, Finland, 00290
GSK Investigational Site
Kinkomaa, Finland, 40930
GSK Investigational Site
Lohja, Finland, 08200
GSK Investigational Site
Mikkeli, Finland, 50100
GSK Investigational Site
Pori, Finland, 28100
GSK Investigational Site
Oulainen, Finland, 86300
France
GSK Investigational Site
Toulouse Cedex 9, France, 31059
GSK Investigational Site
Lomme, France, 59160
GSK Investigational Site
Nantes, France, 44000
GSK Investigational Site
Lille, France, 59800
GSK Investigational Site
Chamalières, France, 63400
GSK Investigational Site
Caen Cedex, France, 14050
GSK Investigational Site
Saint Quentin, France, 02100
GSK Investigational Site
Marseille Cedex 20, France, 13915
GSK Investigational Site
Verdun, France, 55100
GSK Investigational Site
Nimes, France, 30000
GSK Investigational Site
Cholet, France, 49300
GSK Investigational Site
Paris Cedex 04, France, 75181
GSK Investigational Site
Grenoble, France, 38000
GSK Investigational Site
Bethune Cedex, France, 62408
GSK Investigational Site
Annonay, France, 07100
GSK Investigational Site
Bois Guillaume, France, 76230
GSK Investigational Site
Corbeil Essonne, France, 91100
GSK Investigational Site
Nimes, France, 30900
GSK Investigational Site
Avrille, France, 49240
GSK Investigational Site
Tarbes Cedex 09, France, 65013
GSK Investigational Site
Tours Cedex 1, France, 37000
GSK Investigational Site
Maurepas, France, 78310
Germany
GSK Investigational Site
Berlin, Germany, 10365
GSK Investigational Site
Berlin, Germany, 10551
GSK Investigational Site
Berlin, Germany, 13357
GSK Investigational Site
Berlin, Germany, 10178
Germany, Baden-Wuerttemberg
GSK Investigational Site
Schwetzingen, Baden-Wuerttemberg, Germany, 68723
Germany, Hessen
GSK Investigational Site
Kassel, Hessen, Germany, 34117
GSK Investigational Site
Darmstadt, Hessen, Germany, 64287
Germany, Niedersachsen
GSK Investigational Site
Hannover, Niedersachsen, Germany, 30167
Germany, Nordrhein-Westfalen
GSK Investigational Site
Bielefeld, Nordrhein-Westfalen, Germany, 33602
Germany, Schleswig-Holstein
GSK Investigational Site
Bad Segeberg, Schleswig-Holstein, Germany, 23795
Greece
GSK Investigational Site
Heraklion, Crete, Greece, 71110
GSK Investigational Site
Heraklion, Crete, Greece, 71409
GSK Investigational Site
Maroussi, Athens, Greece, 11526
GSK Investigational Site
Papagos/Athens, Greece, 15669
GSK Investigational Site
Thessaloniki, Greece, 57010
GSK Investigational Site
N. Efkarpia, Thessaloniki, Greece, 564 29
GSK Investigational Site
Patra, Greece, 26226
GSK Investigational Site
Thessaloniki, Greece, 54642
GSK Investigational Site
Chania, Crete, Greece, 73300
GSK Investigational Site
Larisa, Greece, 41110
GSK Investigational Site
Ioannina, Greece, 45500
GSK Investigational Site
Athens, Greece, 15669
Hong Kong
GSK Investigational Site
Kwun Tong, Hong Kong
GSK Investigational Site
Kowloon, Hong Kong
GSK Investigational Site
Tai Po,, Hong Kong
GSK Investigational Site
Aberdeen, Hong Kong
GSK Investigational Site
Lai Chi Kok, Hong Kong
Hungary
GSK Investigational Site
Tatabanya, Hungary, 2800
GSK Investigational Site
Törökbálint, Hungary, 2045
GSK Investigational Site
Cegléd, Hungary, 2700
GSK Investigational Site
Budapest, Hungary, 1529
GSK Investigational Site
Szolnok, Hungary, 5004
GSK Investigational Site
Dunaujvaros, Hungary, 2400
Iceland
GSK Investigational Site
Reykjavik, Iceland, 109
GSK Investigational Site
Fossvogur. Reykjavic, Iceland, 108
Italy, Emilia-Romagna
GSK Investigational Site
Ferrara, Emilia-Romagna, Italy, 44100
Italy, Lombardia
GSK Investigational Site
Milano, Lombardia, Italy, 20152
GSK Investigational Site
Brescia, Lombardia, Italy, 25123
GSK Investigational Site
Sesto San Giovanni (mi), Lombardia, Italy, 20099
GSK Investigational Site
Tradate (va), Lombardia, Italy, 21049
Italy, Toscana
GSK Investigational Site
Pisa, Toscana, Italy, 56124
Italy, Veneto
GSK Investigational Site
Bussolengo (vr), Veneto, Italy, 37012
Latvia
GSK Investigational Site
Riga, Latvia, LV 1035
GSK Investigational Site
Riga, Latvia, LV 1038
Lithuania
GSK Investigational Site
Kaunas, Lithuania, LT-50009
Malaysia
GSK Investigational Site
Tanjong Bungah, Malaysia, 10450
GSK Investigational Site
Kubang Kerian, Malaysia, 16150
GSK Investigational Site
Kuching, Malaysia, 93586
GSK Investigational Site
Kuala Lumpur, Malaysia, 50586
Mexico
GSK Investigational Site
Mexico, D.f., Mexico, 06720
GSK Investigational Site
Mexico, Mexico, 14000
Mexico, Jalisco
GSK Investigational Site
Guadalajara, Jalisco, Mexico, 44340
Netherlands
GSK Investigational Site
Hoofddorp, Netherlands, 2130 AT
GSK Investigational Site
Breda, Netherlands, 4819 EV
GSK Investigational Site
Heerlen, Netherlands, 6419 PC
GSK Investigational Site
Utrecht, Netherlands, 2584 CX
GSK Investigational Site
Zwolle, Netherlands, 8025 AB
GSK Investigational Site
Hengelo, Netherlands, 7555 DL
GSK Investigational Site
Ede, Netherlands, 6716 RP
GSK Investigational Site
Dordrecht, Netherlands, 3317 NM
GSK Investigational Site
Arnhem, Netherlands, 6815 AD
GSK Investigational Site
Roosendaal, Netherlands, 4708 AE
GSK Investigational Site
Terneuzen, Netherlands, 4535 PA
New Zealand
GSK Investigational Site
Tauranga, New Zealand, 3001
GSK Investigational Site
Wellington 6004, New Zealand, 6004
GSK Investigational Site
Auckland, New Zealand, 1701
GSK Investigational Site
Hamilton, New Zealand, 2001
GSK Investigational Site
Wellington South, New Zealand, 6002
GSK Investigational Site
Auckland, New Zealand, 1001
GSK Investigational Site
Auckland, New Zealand, 1005
Norway
GSK Investigational Site
Bardufoss, Norway, 9325
GSK Investigational Site
Bodo, Norway, N-8092
GSK Investigational Site
Oslo, Norway, N-0456
GSK Investigational Site
Sandvika, Norway, 1337
GSK Investigational Site
Harstad, Norway, N-9480
GSK Investigational Site
Oslo, Norway, 1150
GSK Investigational Site
Alesund, Norway, 6026
GSK Investigational Site
Skien, Norway, 3722
GSK Investigational Site
Volda, Norway, 6100
GSK Investigational Site
Bergen, Norway, 5053
GSK Investigational Site
Oslo, Norway, N-0514
GSK Investigational Site
Oslo, Norway, N-1054
GSK Investigational Site
Tonsberg, Norway, N-3117
GSK Investigational Site
Trondheim, Norway, 7006
Pakistan
GSK Investigational Site
Lahore, Pakistan
Philippines
GSK Investigational Site
Manila, Philippines, 1000
GSK Investigational Site
Quezon City, Philippines, 1101
GSK Investigational Site
Cebu City, Philippines, 6000
GSK Investigational Site
Manila, Philippines
Poland
GSK Investigational Site
Warszawa, Poland, 01-138
GSK Investigational Site
Zabrze, Poland, 41-800
GSK Investigational Site
Bialystok, Poland, 15-276
GSK Investigational Site
Wroclaw, Poland, 50-449
GSK Investigational Site
Katowice, Poland, 40-752
Puerto Rico
GSK Investigational Site
Ponce, Puerto Rico, 731
Romania
GSK Investigational Site
Bucharest, Romania, 050159
GSK Investigational Site
Brasov, Romania, 2200
GSK Investigational Site
Bucharest, Romania, 050098
GSK Investigational Site
Iasi, Romania, 700115
Russian Federation
GSK Investigational Site
Moscow, Russian Federation, 109240
GSK Investigational Site
Moscow, Russian Federation, 121 359
GSK Investigational Site
Moscow, Russian Federation, 105 077
Singapore
GSK Investigational Site
Singapore, Singapore, 238869
GSK Investigational Site
Singapore, Singapore, 119074
GSK Investigational Site
Singapore, Singapore, 169608
GSK Investigational Site
Singapore, Singapore, 308433
Slovakia
GSK Investigational Site
Banska Bystrica, Slovakia, 974 01
GSK Investigational Site
Kralovsky Chlmec, Slovakia, 077 01
GSK Investigational Site
Nove Zamky, Slovakia, 940 34
GSK Investigational Site
Partizanske, Slovakia, 958 01
South Africa
GSK Investigational Site
Pretoria, South Africa
GSK Investigational Site
Cape Town, South Africa, 8001
GSK Investigational Site
Cape Town, South Africa, 7505
GSK Investigational Site
Pretoria, South Africa, 0040
GSK Investigational Site
Mowbray, South Africa, 7700
Spain
GSK Investigational Site
Santiago de Compostela, Spain, 15706
GSK Investigational Site
Guadalajara, Spain, 19002
GSK Investigational Site
Barcelona, Spain, 08035
GSK Investigational Site
Vigo/Pontevedra, Spain, 36200
GSK Investigational Site
Cadiz, Spain, 11009
GSK Investigational Site
Valencia, Spain, 46017
GSK Investigational Site
Madrid, Spain, 28040
GSK Investigational Site
Madrid, Spain, 28047
GSK Investigational Site
La Coruña, Spain, 15006
GSK Investigational Site
Barakaldo (Vizcaya), Spain, 48903
GSK Investigational Site
Orihuela/Alicante, Spain, 03314
GSK Investigational Site
Alicante, Spain
GSK Investigational Site
Elda, Spain, 03600
GSK Investigational Site
Cartagena, Spain, 30203
GSK Investigational Site
Vizcaya, Spain, 48902
Sweden
GSK Investigational Site
Göteborg, Sweden, SE-413 45
GSK Investigational Site
Boden, Sweden, SE-961 64
GSK Investigational Site
Trollhättan, Sweden, SE-461 85
GSK Investigational Site
Lidköping, Sweden, SE-531 85
GSK Investigational Site
Helsingborg, Sweden, SE-251 87
GSK Investigational Site
Eksjö, Sweden, SE-575 81
GSK Investigational Site
Helsingborg, Sweden, SE-252 26
Taiwan
GSK Investigational Site
Taipei, Taiwan, 112
GSK Investigational Site
Taichung, Taiwan, 40705
GSK Investigational Site
Tainan, Taiwan, 704
GSK Investigational Site
Tau-Yuan County, Taiwan, 333
GSK Investigational Site
Kaohsiung, Taiwan, 80708
Thailand
GSK Investigational Site
Bangkok, Thailand, 10330
GSK Investigational Site
ChiangMai, Thailand, 50200
Ukraine
GSK Investigational Site
Kiev, Ukraine, 03680
United Kingdom
GSK Investigational Site
London, United Kingdom, E1 1BB
United Kingdom, Devon
GSK Investigational Site
Exeter, Devon, United Kingdom, EX2 5DW
United Kingdom, Gloucestershire
GSK Investigational Site
Bristol, Gloucestershire, United Kingdom, BS16 2EW
United Kingdom, Lancashire
GSK Investigational Site
Liverpool, Lancashire, United Kingdom, L9 7AL
GSK Investigational Site
Manchester, Lancashire, United Kingdom, M8 5RB
United Kingdom, Northumberland
GSK Investigational Site
Newcastle Upon Tyne, Northumberland, United Kingdom, NE1 4LP
United Kingdom, Oxfordshire
GSK Investigational Site
Headington, Oxfordshire, United Kingdom, OX3 7LJ
Sponsors and Collaborators
GlaxoSmithKline
Investigators
Study Director: GSK Clinical Trials, MD GlaxoSmithKline
  More Information

No publications provided by GlaxoSmithKline

Additional publications automatically indexed to this study by National Clinical Trials Identifier (NCT ID):
Responsible Party: GSK ( Study Director )
Study ID Numbers: SCO30003
Study First Received: December 20, 2005
Last Updated: November 5, 2009
ClinicalTrials.gov Identifier: NCT00268216     History of Changes
Health Authority: United States: Food and Drug Administration;   United Kingdom: Medicines and Healthcare Products Regulatory Agency;   Australia: Department of Health and Ageing Therapeutic Goods Administration

Keywords provided by GlaxoSmithKline:
TORCH
COPD
ADVAIR
SERETIDE
mortality

Additional relevant MeSH terms:
Anti-Inflammatory Agents
Respiratory System Agents
Neurotransmitter Agents
Salmeterol
Adrenergic beta-Agonists
Adrenergic Agents
Molecular Mechanisms of Pharmacological Action
Physiological Effects of Drugs
Respiration Disorders
Anti-Asthmatic Agents
Anti-Allergic Agents
Adrenergic Agonists
Pharmacologic Actions
Lung Diseases, Obstructive
Respiratory Tract Diseases
Autonomic Agents
Therapeutic Uses
Lung Diseases
Fluticasone
Peripheral Nervous System Agents
Dermatologic Agents
Bronchodilator Agents
Pulmonary Disease, Chronic Obstructive

ClinicalTrials.gov processed this record on November 27, 2009